AVADEL PHARMACEUTICALS PLC (AVDL) - Insider Holders & Insider Ownership

List of insiders holdings for AVADEL PHARMACEUTICALS PLC:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
#Insider Holder NameReport
Date Time		Shares Owned
Directly
Indirectly		Total
Shares Owned		Filing
1KOTLER KEVIN
Broadfin Capital LLC
Broadfin Healthcare Master Fund Ltd
Director		2020-02-13 17:26:451,029,012
0		1,029,012Form 13G
2THOMPSON PHILLANDAS T.
See Remarks		2019-03-11 19:16:08688,671
0		688,671Form 4
3Divis Gregory J
Chief Executive Officer		2025-03-07 16:06:44521,100
10,000		531,100Form 4
4KANAN MICHAEL F
See Remarks		2019-03-11 19:10:54410,538
0		410,538Form 4
5DUBOW JORDAN
Chief Medical Officer		2019-04-30 17:51:39340,000
0		340,000Form 4
6Rodriguez Susan
Chief Operating Officer		2025-05-13 18:01:12300,000
0		300,000Form 4
7Williamson Douglas J
Chief Medical Officer		2022-02-16 16:40:17275,000
0		275,000Form 4
8MONTEITH DAVID
See Remarks		2017-10-11 16:28:39252,500
0		252,500Form 4
9MACKE SCOTT A.
See Remarks		2017-10-11 16:27:33233,500
0		233,500Form 4
10Ende Eric J
Director		2025-07-31 16:07:44230,900
0		230,900Form 4
11DAVIS GREGORY J.
See Remarks		2017-10-11 16:25:22195,000
0		195,000Form 4
12CERUTTI GUILLAUME
See Remarks		2017-06-30 16:17:54183,440
0		183,440Form 4
13MCHUGH THOMAS S
Chief Financial Officer		2025-03-07 16:07:45172,400
0		172,400Form 4
14VAN ASSCHE BENOIT
See Remarks		2018-07-20 16:11:57169,417
0		169,417Form 4
15NAVARRE CHRISTOPHE
See Remarks		2018-07-20 16:08:47169,417
0		169,417Form 4
16FILDES FRANCIS
See Remarks		2018-07-20 16:07:19150,859
0		150,859Form 4
17Vaughn Jason
Sr. VP, Technical Operations		2019-11-14 17:11:10150,000
0		150,000Form 4
18Kim Richard J
Chief Commercial Officer		2024-03-04 06:28:57147,000
0		147,000Form 4
19D'SILVA DHIREN
VP Irish & European Operations		2018-02-07 16:06:26145,000
0		145,000Form 4
20Thornton Peter J.
Director		2025-07-31 16:09:06126,055
0		126,055Form 4
21Elrod Marcus W
See Remarks		2017-10-11 16:26:28125,400
0		125,400Form 4
22SULLIVAN STEPHEN G.
See Remarks		2017-10-11 16:29:48125,000
0		125,000Form 4
23Seurer Jerad G.
Gen. Counsel & Corp. Secretary		2025-03-07 16:09:00107,495
0		107,495Form 4
24McCamish Mark Anthony
Director		2025-07-31 16:10:5233,000
67,025		100,025Form 4
25Hatten Sandra L
See Remarks		2019-12-16 16:21:1155,765
3,400		59,165Form 4
26Amin Naseem
Director		2025-07-31 16:06:4933,000
0		33,000Form 4
27Glass Geoffrey Michael
Director		2025-09-15 19:53:580
11,000		11,000Form 4
28Palczuk Linda
Director		2025-09-15 19:54:410
11,000		11,000Form 4
29NOHRA GUY P
See Footnotes		2003-10-03 17:46:280
6,443		6,443Form 4
30GUSKY DAVID P
See Remarks		2019-07-05 16:05:440
0		0Form 4
31STAPLETON CRAIG R
Director		2019-05-10 16:46:300
0		0Form 4
32ANDERSON MICHAEL S
See Remarks		2019-01-18 16:09:190
0		0Form 4
33Flynn James E
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Private Design Fund II L.P.
Deerfield Special Situations Fund L.P.
Deerfield Mgmt L.P.
Deerfield Private Design International II L.P.
Breaking Stick Holdings LLC
*Possible member of 10% group
10% Owner		2020-02-13 12:38:410
0		0Form 13G
34ALTA PARTNERS
ALTA BIOPHARMA PARTNERS LP
ALTA BIOPHARMA MANAGEMENT LLC
ALTA EMBARCADERO BIOPHARMA PARTNERS LLC
ALTA CHASE BIOPHARMA MANAGEMENT LLC
FLAMEL CHASE PARTNERS ALTA BIO LLC
DELEAGE JEAN
GRUENER GARRETT
JANNEY DANIEL
MARDUEL ALIX
10% Owner		2003-10-09 17:18:490
0		0Form 13D